104 related articles for article (PubMed ID: 21229277)
21. Bioinformatics and immunologic investigation on B and T cell epitopes of Cur l 3, a major allergen of Curvularia lunata.
Sharma V; Singh BP; Gaur SN; Pasha S; Arora N
J Proteome Res; 2009 Jun; 8(6):2650-5. PubMed ID: 19290623
[TBL] [Abstract][Full Text] [Related]
22. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses.
Dakappagari NK; Pyles J; Parihar R; Carson WE; Young DC; Kaumaya PT
J Immunol; 2003 Apr; 170(8):4242-53. PubMed ID: 12682258
[TBL] [Abstract][Full Text] [Related]
23. Invariant chain-peptide fusion vaccine using HER-2/neu.
Perez SA; Peoples GE; Papamichail M; Baxevanis CN
Methods Mol Biol; 2014; 1139():321-36. PubMed ID: 24619690
[TBL] [Abstract][Full Text] [Related]
24. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with a potent DNA vaccine targeting B-cell epitopes of hGRP induces prophylactic and therapeutic antitumor activity in vivo.
Yong L; Huiyong Z; Jing H; Huaqian W; Xiangbing H; Yanjun M; Xiaoyu G; Li H; Yanan Y; Rongyue C; Hao F; Jingjing L; Jie W
Gene Ther; 2010 Apr; 17(4):459-68. PubMed ID: 20130655
[TBL] [Abstract][Full Text] [Related]
26. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.
De Groot AS; Bishop EA; Khan B; Lally M; Marcon L; Franco J; Mayer KH; Carpenter CC; Martin W
Methods; 2004 Dec; 34(4):476-87. PubMed ID: 15542374
[TBL] [Abstract][Full Text] [Related]
27. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
28. Validation of in silico prediction by in vitro immunoserological results of fine epitope mapping on citrate synthase specific autoantibodies.
Nyárády Z; Czömpöly T; Bosze S; Nagy G; Petrohai A; Pál J; Hudecz F; Berki T; Németh P
Mol Immunol; 2006 Mar; 43(7):830-8. PubMed ID: 16087237
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
30. Candidate epitope identification using peptide property models: application to cancer immunotherapy.
Sung MH; Simon R
Methods; 2004 Dec; 34(4):460-7. PubMed ID: 15542372
[TBL] [Abstract][Full Text] [Related]
31. In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer.
Taheri-Anganeh M; Amiri A; Movahedpour A; Khatami SH; Ghasemi Y; Savardashtaki A; Mostafavi-Pour Z
Iran Biomed J; 2020 May; 24(3):173-82. PubMed ID: 31952435
[TBL] [Abstract][Full Text] [Related]
32. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
Sinnathamby G; Lauer P; Zerfass J; Hanson B; Karabudak A; Krakover J; Secord AA; Clay TM; Morse MA; Dubensky TW; Brockstedt DG; Philip R; Giedlin M
J Immunother; 2009 Oct; 32(8):856-69. PubMed ID: 19752748
[TBL] [Abstract][Full Text] [Related]
33. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.
Bazhan SI; Karpenko LI; Lebedev LR; Uzhachenko RV; Belavin PA; Eroshkin AM; Ilyichev AA
Mol Immunol; 2008 Feb; 45(3):661-9. PubMed ID: 17869341
[TBL] [Abstract][Full Text] [Related]
34. Subunit peptide cancer vaccines targeting activating mutations of the p21 ras proto-oncogene.
Triozzi PL; Stoner GD; Kaumaya PT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):185-92. PubMed ID: 9346851
[TBL] [Abstract][Full Text] [Related]
35. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
Schroers R; Huang XF; Hammer J; Zhang J; Chen SY
Cancer Res; 2002 May; 62(9):2600-5. PubMed ID: 11980655
[TBL] [Abstract][Full Text] [Related]
36. MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancer.
Morse MA; Secord AA; Blackwell K; Hobeika AC; Sinnathamby G; Osada T; Hafner J; Philip M; Clay TM; Lyerly HK; Philip R
Clin Cancer Res; 2011 May; 17(10):3408-19. PubMed ID: 21300761
[TBL] [Abstract][Full Text] [Related]
37. Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity.
Tian H; He Y; Song X; Jiang L; Luo J; Xu Y; Zhang W; Gao X; Yao W
Cancer Lett; 2018 Aug; 430():79-87. PubMed ID: 29778570
[TBL] [Abstract][Full Text] [Related]
38. Structure-based peptide mimicry of tumor-associated antigens.
Ohtaki A; Kieber-Emmons T; Murali R
Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):1-5. PubMed ID: 23600498
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of a xenogeneic multi-epitope HER2
Gül A; Döşkaya M; Can H; Karakavuk M; Anıl-İnevi M; Sağlam-Metiner P; Atalay-Şahar E; Değirmenci-Döşkaya A; Zekioğlu O; Gürüz AY; Gülce-Iz S; Yeniay L
Vaccine; 2022 Apr; 40(16):2409-2419. PubMed ID: 35305824
[TBL] [Abstract][Full Text] [Related]
40. Conglomeration of novel Culex quinquefasciatus salivary proteins to contrive multi-epitope subunit vaccine against infections caused by blood imbibing transmitter.
Ojha R; Khatoon N; Prajapati VK
Int J Biol Macromol; 2018 Oct; 118(Pt A):834-843. PubMed ID: 29953889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
